442 related articles for article (PubMed ID: 11690622)
1. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis.
Leppert D; Lindberg RL; Kappos L; Leib SL
Brain Res Brain Res Rev; 2001 Oct; 36(2-3):249-57. PubMed ID: 11690622
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis.
Muroski ME; Roycik MD; Newcomer RG; Van den Steen PE; Opdenakker G; Monroe HR; Sahab ZJ; Sang QX
Curr Pharm Biotechnol; 2008 Feb; 9(1):34-46. PubMed ID: 18289055
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain.
Gasche Y; Soccal PM; Kanemitsu M; Copin JC
Front Biosci; 2006 May; 11():1289-301. PubMed ID: 16368516
[TBL] [Abstract][Full Text] [Related]
4. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia.
Candelario-Jalil E; Yang Y; Rosenberg GA
Neuroscience; 2009 Feb; 158(3):983-94. PubMed ID: 18621108
[TBL] [Abstract][Full Text] [Related]
5. [Role of matrix metalloproteinases in the pathogenesis of multiple sclerosis].
Kurzepa J; Bartosik-Psujek H; Suchozebrska-Jesionek D; Rejdak K; Stryjecka-Zimmer M; Stelmasiak Z
Neurol Neurochir Pol; 2005; 39(1):63-7. PubMed ID: 15735992
[TBL] [Abstract][Full Text] [Related]
6. Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives.
Behl T; Kaur G; Sehgal A; Bhardwaj S; Singh S; Buhas C; Judea-Pusta C; Uivarosan D; Munteanu MA; Bungau S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573368
[TBL] [Abstract][Full Text] [Related]
7. Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood-brain barrier opening in rodents: Differences in response based on strains and solvents.
Rosenberg GA; Estrada EY; Mobashery S
Brain Res; 2007 Feb; 1133(1):186-92. PubMed ID: 17184743
[TBL] [Abstract][Full Text] [Related]
8. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
Levin M; Udi Y; Solomonov I; Sagi I
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
[TBL] [Abstract][Full Text] [Related]
9. Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases.
Kim IS; Yang WS; Kim CH
Curr Med Chem; 2023; 30(18):2075-2112. PubMed ID: 36017851
[TBL] [Abstract][Full Text] [Related]
10. [Matrix metalloproteinases and their inhibitors, modulators of neuro-immune interactions and of pathophysiological processes in the nervous system].
Khrestchatisky M; Jourquin J; Ogier C; Charton G; Bernard A; Tremblay E; Rivera S
J Soc Biol; 2003; 197(2):133-44. PubMed ID: 12910628
[TBL] [Abstract][Full Text] [Related]
11. On the structure and functions of gelatinase B/matrix metalloproteinase-9 in neuroinflammation.
Vandooren J; Van Damme J; Opdenakker G
Prog Brain Res; 2014; 214():193-206. PubMed ID: 25410359
[TBL] [Abstract][Full Text] [Related]
12. Endogenous and synthetic MMP inhibitors in CNS physiopathology.
Baranger K; Rivera S; Liechti FD; Grandgirard D; Bigas J; Seco J; Tarrago T; Leib SL; Khrestchatisky M
Prog Brain Res; 2014; 214():313-51. PubMed ID: 25410364
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic implications of the specific inhibition of causative matrix metalloproteinases in experimental colitis induced by dextran sulphate sodium.
Kobayashi K; Arimura Y; Goto A; Okahara S; Endo T; Shinomura Y; Imai K
J Pathol; 2006 Jul; 209(3):376-83. PubMed ID: 16552705
[TBL] [Abstract][Full Text] [Related]
14. Adhesion molecules and matrix metalloproteinases in Multiple Sclerosis: effects induced by Interferon-beta.
Avolio C; Giuliani F; Liuzzi GM; Ruggieri M; Paolicelli D; Riccio P; Livrea P; Trojano M
Brain Res Bull; 2003 Aug; 61(3):357-64. PubMed ID: 12909305
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases in the CNS: interferons get nervous.
Chopra S; Overall CM; Dufour A
Cell Mol Life Sci; 2019 Aug; 76(16):3083-3095. PubMed ID: 31165203
[TBL] [Abstract][Full Text] [Related]
16. MMPs and ADAMs in neurological infectious diseases and multiple sclerosis.
Muri L; Leppert D; Grandgirard D; Leib SL
Cell Mol Life Sci; 2019 Aug; 76(16):3097-3116. PubMed ID: 31172218
[TBL] [Abstract][Full Text] [Related]
17. Imaging matrix metalloproteinase activity in multiple sclerosis as a specific marker of leukocyte penetration of the blood-brain barrier.
Gerwien H; Hermann S; Zhang X; Korpos E; Song J; Kopka K; Faust A; Wenning C; Gross CC; Honold L; Melzer N; Opdenakker G; Wiendl H; Schäfers M; Sorokin L
Sci Transl Med; 2016 Nov; 8(364):364ra152. PubMed ID: 27831901
[TBL] [Abstract][Full Text] [Related]
18. The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system.
Hartung HP; Kieseier BC
J Neuroimmunol; 2000 Jul; 107(2):140-7. PubMed ID: 10854648
[TBL] [Abstract][Full Text] [Related]
19. Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases.
Liuzzi GM; Mastroianni CM; Santacroce MP; Fanelli M; D'Agostino C; Vullo V; Riccio P
J Neurovirol; 2000 Apr; 6(2):156-63. PubMed ID: 10822329
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions.
Maeda A; Sobel RA
J Neuropathol Exp Neurol; 1996 Mar; 55(3):300-9. PubMed ID: 8786388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
